Monitor outcomes to ensure long-term PRRS control success. Track diagnostic results and pig performance data across sow, grow-finish, and whole production systems to detect low-level virus circulation, guide decisions, and move herds toward stable or negative status.
The Guilty Gilt Guide was written with a clear objective – to maximize the whole-herd performance of pig populations by helping gilts to reach their full reproductive potential and produce healthy pigs that reach their full genetic potential during grow-finish.
The open reading frames (ORF)5 represents approximately 4% of the porcine repro- ductive and respiratory syndrome virus (PRRSV)-2 genome (whole-PRRSV) and is often determined by the Sanger technique, which rarely detects >1 PRRSV strain if present in the sample.
Porcine reproductive and respiratory syndrome virus (PRRSV) is an important swine pathogen affecting the global swine industry.
Based on the mortality change, stopping PRRS MLV vaccination resulted in big economic loss in this farm. The benefit-to-cost ratio between non-vaccinated and vaccinated is 7.03:1 based on the mortality alone
The results of this study demonstrated that Ingelvac® PRRS MLV vaccine had a significantly better efficacy in grower-finisher pigs.
The results of this study demonstrated poor efficacy performance using Type I vaccine in the farm positive for PRRSV type II compared to a VR2332 based vaccine.
In conclusion, Ingelvac® PRRS MLV is a useful tool to control and prevent PHFD.